Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 26th:
MCBC Holdings, Inc. (MCFT - Free Report) : This recreational vehicles manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.
MCBC Holdings has a PEG ratio 0.96, compared with 1.24 for the industry. The company possesses a Growth Score of A.
DXC Technology Company (DXC - Free Report) : This information technology services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.
DXC Technology has a PEG ratio 1.23, compared with 7.99 for the industry. The company possesses a Growth Score of A.
Kulicke and Soffa Industries, Inc. (KLIC - Free Report) : This semiconductor equipment manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 32% over the last 60 days.
Kulicke and Soffa Industries has a PEG ratio 0.94, compared with 2.19 for the industry. The company possesses a Growth Score of A.
Huntsman Corporation (HUN - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 12.8% over the last 60 days.
Huntsman has a PEG ratio 1.28, compared with 1.47 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 26th:
MCBC Holdings, Inc. (MCFT - Free Report) : This recreational vehicles manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.7% over the last 60 days.
MCBC Holdings has a PEG ratio 0.96, compared with 1.24 for the industry. The company possesses a Growth Score of A.
DXC Technology Company (DXC - Free Report) : This information technology services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.
DXC Technology has a PEG ratio 1.23, compared with 7.99 for the industry. The company possesses a Growth Score of A.
Kulicke and Soffa Industries, Inc. (KLIC - Free Report) : This semiconductor equipment manufacturer, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 32% over the last 60 days.
Kulicke and Soffa Industries has a PEG ratio 0.94, compared with 2.19 for the industry. The company possesses a Growth Score of A.
Huntsman Corporation (HUN - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 12.8% over the last 60 days.
Huntsman has a PEG ratio 1.28, compared with 1.47 for the industry. The company possesses a Growth Score of A.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HUN - FREE
Get the latest research report on KLIC - FREE
Get the latest research report on MCFT - FREE
Get the latest research report on DXC - FREE